Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies
about
Nanoparticle Uptake: The Phagocyte ProblemUnderstanding the relationship between biotherapeutic protein stability and solid-liquid interfacial shear in constant region mutants of IgG1 and IgG4Protein quantity on the air-solid interface determines degradation rates of human growth hormone in lyophilized samples.Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface.Response of a concentrated monoclonal antibody formulation to high shearUnderstanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.Aggregation of a monoclonal antibody induced by adsorption to stainless steelEffects of shear on proteins in solution.Protein particulate detection issues in biotherapeutics development--current status.Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy.Why the Immune System Should Be Concerned by Nanomaterials?Influence of particle shedding from silicone tubing on antibody stability.Real-time observation of protein aggregates in pharmaceutical formulations using liquid cell electron microscopy.Adsorption behavior of a human monoclonal antibody at hydrophilic and hydrophobic surfaces.Effect of thermal stability on protein adsorption to silica using homologous aldo-keto reductases.Size and surface chemistry of nanoparticles lead to a variant behavior in the unfolding dynamics of human carbonic anhydrase.Protein-protein interactions controlling interfacial aggregation of rhIL-1ra are not described by simple colloid models.Protein Adsorption and Layer Formation at the Stainless Steel-Solution Interface Mediates Shear-Induced Particle Formation for an IgG1 Monoclonal Antibody.
P2860
Q28395287-2FF37EE3-39A9-4566-95FD-E0DB63561617Q30357075-7D500624-7631-4C71-A9EA-FCC5CF2AA88FQ30360134-F4E11396-AC39-458F-9C49-0B5005372399Q30362843-F167E77E-E480-4000-B95B-FBB8ED84808CQ30480156-E22D68DC-D597-4F0E-94C0-5217C5592194Q36739647-6B5C4F13-2830-4BCF-966B-24EDE6D97705Q37588048-A0C22EAC-7913-44FC-9E5D-D533B2BDA886Q37810518-0A6E86FC-2B73-4DC7-9CEA-EBA2007BFBE0Q38008257-53F06DD0-428E-4A1E-890B-12BC6C4BFCC5Q39162597-629E191D-8237-4A3B-AD31-D668B869214DQ39336982-2DE6E001-576E-4585-A3D6-D5C884D79C8AQ39639332-509FA7D9-1C57-45A9-AE55-DC3C1BEBB797Q40994930-B894F4CA-4343-40E2-BA56-5FC02E926557Q41931928-283B1C8E-B75A-4E25-B2BA-5583038E44EDQ42533583-F7B5D562-10AA-49F6-B575-80F94243E127Q47355942-3429C299-A128-4F94-938D-903FF3CFC0F5Q47693273-A8A7F277-3423-4BF9-BDEA-C718011A7D2DQ50100194-88908AD4-97FC-45C7-B719-6335024646BB
P2860
Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Monoclonal antibody interactio ...... and accelerated stress studies
@en
Monoclonal antibody interactio ...... nd accelerated stress studies.
@nl
type
label
Monoclonal antibody interactio ...... and accelerated stress studies
@en
Monoclonal antibody interactio ...... nd accelerated stress studies.
@nl
prefLabel
Monoclonal antibody interactio ...... and accelerated stress studies
@en
Monoclonal antibody interactio ...... nd accelerated stress studies.
@nl
P2093
P2860
P356
P1476
Monoclonal antibody interactio ...... and accelerated stress studies
@en
P2093
David Chiu
Erwin Freund
Jared S Bee
Jennifer L Stevenson
John F Carpenter
Koustuv Chatterjee
Suzanne Sawicki
P2860
P304
P356
10.1002/JPS.21768
P407
P577
2009-09-01T00:00:00Z